Nanomedicine-mediated cancer stem cell therapy

Area of Science:

• Oncology
• Nanotechnology
• Drug Delivery

Background:

• Tumors are heterogeneous, containing cancer stem cells (CSCs) crucial for progression, drug resistance, recurrence, and metastasis.
• CSCs present a significant challenge to cancer therapy due to their self-renewal and survival capabilities.
• Existing therapeutic strategies aim to target CSCs through various mechanisms, but face limitations.

Purpose of the Study:

• To review biological processes related to CSCs and highlight strategies for targeting drug-resistant CSCs.
• To present state-of-the-art nanomedicine approaches for CSC elimination.
• To offer a perspective on future innovative therapeutic strategies and nanomedicine-based CSC therapy.

Main Methods:

• Review of current literature on CSC biology and therapeutic strategies.
• Focus on nanomedicine approaches, including nanocarriers and intelligent nanomedicines.
• Analysis of drug delivery technologies for overcoming CSC-specific agent limitations.

Main Results:

• Nanocarrier-based agents can penetrate CSC niches and enhance drug accumulation.
• Intelligent nanomedicine shows potential in overcoming multidrug resistance and reducing toxicity to normal stem cells.
• Various therapeutic agents and strategies are being developed to selectively target CSCs.

Conclusions:

• Targeting cancer stem cells is essential for effective cancer therapy.
• Nanomedicine provides innovative solutions for delivering anti-CSC agents and overcoming resistance mechanisms.
• Future research should focus on developing advanced nanomedicine for improved CSC-targeted cancer treatment.